Xarelto Lawsuit Filings Expected To Increase As Bellwether Trial Dates For MDL 2592 Are Set

September 30, 2016 – – TheProductLawyers.com provides details on the latest developments in the many lawsuits filed against the makers of Xarelto. With more than 2,000 cases already filed against Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) and Bayer AG, the federal Judicial Panel on Multidistrict Litigation elected to consolidate them. This consolidation of cases into MDL No. 2592 will expedite the process of law and ensure a resolution is reached more swiftly. The litigation will be carried out in the Eastern District of Louisiana under the supervision of Judge Eldon Fallon.

However, prior to the main case hearings, four bellwether cases have been selected. These will enable counsel to observe the reactions of jury panels to presented evidence and testimony. The first and second cases will be presented in the Eastern District of Louisiana on February 6th and March 13th of 2017. The third and fourth cases have been relocated to other districts, and will be heard on April 24th and May 30th of 2017.

Initially following its 2011 FDA approval, Xarelto was hailed as a breakthrough in the treatment of blood clots. However, after several years it receives a somewhat lackluster appraisal from both patients and physicians. In fact, the plaintiffs allege that the new-generation blood thinner placed them at a substantially elevated risk for catastrophic bleeding episodes and that the manufacturers were negligent in their responsibility to apprise both doctors and the public of this risk.

While the litigation moves forward in the Eastern District of Louisiana, the Philadelphia Court of Common Pleas has also consolidated Xarelto lawsuits into a mass tort program. Comprised of 550 separate suits with allegations of harm leveled against the pharmaceutical companies, the mass tort program claims are similar to those of MDL No. 2592.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.

###

Contact TheProductLawyers.com:

Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60012384